Nurix Therapeutics IncNASDAQ:NRIX
- LAST PRICE22.0900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots20.6800/ 1
- Ask / Lots26.5000/ 15
- Open / Previous Close--- / 22.0900
- Day Range---
- 52 Week Range
- Volume1
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NRIX |
|---|---|---|
| 09:32 ET | 3350 | 22.545 |
| 09:34 ET | 742 | 22.54 |
| 09:36 ET | 6543 | 22.57 |
| 09:38 ET | 400 | 22.57 |
| 09:39 ET | 407 | 22.58 |
| 09:41 ET | 400 | 22.565 |
| 09:43 ET | 16149 | 22.55 |
| 09:48 ET | 2100 | 22.655 |
| 09:50 ET | 3700 | 22.67 |
| 09:52 ET | 700 | 22.675 |
| 09:54 ET | 341 | 22.675 |
| 09:56 ET | 1064 | 22.5981 |
| 09:57 ET | 19828 | 22.81 |
| 09:59 ET | 1738 | 22.79 |
| 10:01 ET | 8059 | 23.04 |
| 10:03 ET | 18236 | 22.95 |
| 10:06 ET | 20700 | 23.05 |
| 10:08 ET | 88444 | 22.88 |
| 10:10 ET | 2200 | 22.795 |
| 10:12 ET | 800 | 22.785 |
| 10:14 ET | 2629 | 22.7389 |
| 10:15 ET | 392 | 22.707 |
| 10:17 ET | 600 | 22.615 |
| 10:19 ET | 1000 | 22.435 |
| 10:21 ET | 2261 | 22.51 |
| 10:24 ET | 904 | 22.525 |
| 10:26 ET | 934 | 22.55 |
| 10:28 ET | 1361 | 22.58 |
| 10:30 ET | 2194 | 22.625 |
| 10:32 ET | 4702 | 22.75 |
| 10:33 ET | 13835 | 22.65 |
| 10:35 ET | 200 | 22.645 |
| 10:37 ET | 1300 | 22.59 |
| 10:42 ET | 809 | 22.35 |
| 10:44 ET | 1062 | 22.355 |
| 10:46 ET | 4695 | 22.355 |
| 10:48 ET | 912 | 22.42 |
| 10:50 ET | 900 | 22.355 |
| 10:51 ET | 500 | 22.33 |
| 10:53 ET | 1699 | 22.35 |
| 10:55 ET | 3600 | 22.375 |
| 10:57 ET | 700 | 22.38 |
| 11:00 ET | 1210 | 22.435 |
| 11:02 ET | 1605 | 22.44 |
| 11:04 ET | 9332 | 22.415 |
| 11:06 ET | 2402 | 22.345 |
| 11:08 ET | 2110 | 22.275 |
| 11:09 ET | 5187 | 22.21 |
| 11:11 ET | 500 | 22.2 |
| 11:13 ET | 1400 | 22.175 |
| 11:15 ET | 2156 | 22.195 |
| 11:18 ET | 27640 | 21.82 |
| 11:20 ET | 16971 | 21.75 |
| 11:22 ET | 700 | 21.84 |
| 11:24 ET | 1600 | 21.93 |
| 11:26 ET | 1016 | 21.88 |
| 11:27 ET | 7903 | 22 |
| 11:29 ET | 600 | 22 |
| 11:31 ET | 700 | 22.025 |
| 11:33 ET | 1367 | 21.975 |
| 11:36 ET | 500 | 22.02 |
| 11:38 ET | 400 | 22.02 |
| 11:40 ET | 400 | 22.02 |
| 11:42 ET | 500 | 22.05 |
| 11:44 ET | 500 | 22.06 |
| 11:45 ET | 5800 | 22.2 |
| 11:47 ET | 500 | 22.1801 |
| 11:49 ET | 1293 | 22.19 |
| 11:51 ET | 2950 | 22.11 |
| 11:54 ET | 200 | 22.054 |
| 11:56 ET | 1600 | 22.1 |
| 11:58 ET | 1200 | 22.06 |
| 12:00 ET | 713 | 22.05 |
| 12:02 ET | 1000 | 22.04 |
| 12:03 ET | 1862 | 22.12 |
| 12:05 ET | 300 | 22.145 |
| 12:07 ET | 400 | 22.155 |
| 12:09 ET | 800 | 22.14 |
| 12:12 ET | 200 | 22.14 |
| 12:14 ET | 2700 | 22.3 |
| 12:16 ET | 300 | 22.29 |
| 12:18 ET | 1400 | 22.255 |
| 12:20 ET | 300 | 22.21 |
| 12:21 ET | 300 | 22.245 |
| 12:23 ET | 100 | 22.22 |
| 12:25 ET | 1103 | 22.205 |
| 12:27 ET | 300 | 22.17 |
| 12:30 ET | 800 | 22.195 |
| 12:32 ET | 5396 | 22.21 |
| 12:34 ET | 2922 | 22.17 |
| 12:36 ET | 2400 | 22.25 |
| 12:38 ET | 600 | 22.245 |
| 12:41 ET | 10500 | 22.15 |
| 12:45 ET | 500 | 22.165 |
| 12:48 ET | 2658 | 22.1 |
| 12:50 ET | 500 | 22.11 |
| 12:52 ET | 300 | 22.16 |
| 12:54 ET | 800 | 22.2 |
| 12:56 ET | 1000 | 22.27 |
| 12:57 ET | 3102 | 22.165 |
| 12:59 ET | 200 | 22.165 |
| 01:01 ET | 100 | 22.1 |
| 01:03 ET | 1800 | 22.075 |
| 01:06 ET | 1400 | 22.075 |
| 01:08 ET | 2319 | 22.045 |
| 01:10 ET | 900 | 22.035 |
| 01:12 ET | 1000 | 22.03 |
| 01:14 ET | 2771 | 21.99 |
| 01:15 ET | 1848 | 22.01 |
| 01:17 ET | 700 | 21.905 |
| 01:19 ET | 1700 | 21.82 |
| 01:21 ET | 300 | 21.815 |
| 01:24 ET | 300 | 21.83 |
| 01:26 ET | 3092 | 21.7 |
| 01:28 ET | 600 | 21.755 |
| 01:30 ET | 300 | 21.75 |
| 01:32 ET | 400 | 21.765 |
| 01:33 ET | 1400 | 21.875 |
| 01:35 ET | 1770 | 21.92 |
| 01:37 ET | 1100 | 21.88 |
| 01:39 ET | 400 | 21.85 |
| 01:42 ET | 200 | 21.8483 |
| 01:44 ET | 200 | 21.88 |
| 01:46 ET | 400 | 21.94 |
| 01:48 ET | 600 | 21.92 |
| 01:50 ET | 618 | 21.955 |
| 01:51 ET | 1500 | 22.055 |
| 01:53 ET | 1429 | 22.06 |
| 01:55 ET | 200 | 22.06 |
| 01:57 ET | 700 | 22.1 |
| 02:00 ET | 400 | 22.07 |
| 02:02 ET | 1450 | 22.13 |
| 02:04 ET | 300 | 22.17 |
| 02:06 ET | 716 | 22.16 |
| 02:08 ET | 626 | 22.15 |
| 02:09 ET | 800 | 22.1 |
| 02:11 ET | 1910 | 22.0914 |
| 02:13 ET | 500 | 22.13 |
| 02:15 ET | 1149 | 22.17 |
| 02:18 ET | 1840 | 22.2 |
| 02:20 ET | 855 | 22.16 |
| 02:22 ET | 200 | 22.155 |
| 02:26 ET | 400 | 22.155 |
| 02:27 ET | 1400 | 22.15 |
| 02:29 ET | 11600 | 22.175 |
| 02:31 ET | 900 | 22.22 |
| 02:33 ET | 913 | 22.17 |
| 02:36 ET | 200 | 22.17 |
| 02:38 ET | 500 | 22.1 |
| 02:40 ET | 2800 | 22.14 |
| 02:42 ET | 2700 | 22.23 |
| 02:44 ET | 831 | 22.2475 |
| 02:45 ET | 800 | 22.235 |
| 02:47 ET | 27200 | 22.39 |
| 02:49 ET | 300 | 22.375 |
| 02:51 ET | 6214 | 22.405 |
| 02:54 ET | 14968 | 22.425 |
| 02:56 ET | 500 | 22.47 |
| 02:58 ET | 1109 | 22.55 |
| 03:00 ET | 1120 | 22.52 |
| 03:02 ET | 1012 | 22.58 |
| 03:03 ET | 400 | 22.585 |
| 03:05 ET | 400 | 22.585 |
| 03:07 ET | 768 | 22.59 |
| 03:09 ET | 10900 | 22.405 |
| 03:12 ET | 10861 | 22.38 |
| 03:14 ET | 400 | 22.35 |
| 03:16 ET | 1410 | 22.3006 |
| 03:18 ET | 2009 | 22.37 |
| 03:20 ET | 1600 | 22.35 |
| 03:21 ET | 700 | 22.35 |
| 03:23 ET | 600 | 22.37 |
| 03:25 ET | 900 | 22.345 |
| 03:27 ET | 300 | 22.345 |
| 03:30 ET | 2524 | 22.28 |
| 03:32 ET | 2994 | 22.19 |
| 03:34 ET | 714 | 22.155 |
| 03:36 ET | 300 | 22.15 |
| 03:38 ET | 1450 | 22.02 |
| 03:39 ET | 3653 | 22.04 |
| 03:41 ET | 1034 | 22.06 |
| 03:43 ET | 1414 | 22.065 |
| 03:45 ET | 1700 | 22.005 |
| 03:48 ET | 4693 | 21.93 |
| 03:50 ET | 3216 | 21.95 |
| 03:52 ET | 5799 | 21.855 |
| 03:54 ET | 8219 | 21.89 |
| 03:56 ET | 9362 | 22.05 |
| 03:57 ET | 6200 | 22.08 |
| 03:59 ET | 113900 | 22.09 |
Sep 30, 2024
Nurix Therapeutics Announces Presentations at Discovery on Target Conference, from 7:00AM ET on Monday Sep 30, 2024 by Dow Jones
7:00AM ET on Monday Sep 30, 2024 by Dow Jones
Sep 6, 2024
Nurix Therapeutics To Participate in Upcoming ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit, from 7:00AM ET on Friday Sep 06, 2024 by Dow Jones
7:00AM ET on Friday Sep 06, 2024 by Dow Jones
Sep 4, 2024
DJ Nurix Therapeutics Is Maintained at Outperform by Oppenheimer, from 1:10PM ET on Wednesday Sep 04, 2024 by Dow Jones
1:10PM ET on Wednesday Sep 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nurix Therapeutics Inc | 1.4B | -7.6x | --- |
Immatics NV | 1.2B | -12.2x | --- |
Arcus Biosciences Inc | 1.4B | -5.0x | --- |
Arvinas Inc | 1.7B | -4.7x | --- |
Arcutis Biotherapeutics Inc | 1.1B | -4.4x | --- |
Vir Biotechnology Inc | 1.0B | -2.1x | --- |
Company Information
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of small molecules and antibody therapies based on the modulation of cellular protein levels as a treatment approach for cancer, inflammatory conditions and other diseases. It DELigase is an integrated discovery platform, to identify and advance drug candidates targeting E3 ligases. Its drug candidates include NX-2127, NX-5948 and NX-1607. NX-2127 is an orally bioavailable Brutons tyrosine kinase (BTK) degrader that also degrades cereblon neosubstrates IKZF1 (Ikaros) and IKZF3 (Aiolos) for the treatment of relapsed or refractory B-cell malignancies. NX-5948 is an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and potentially autoimmune diseases. NX-1607 is an oral clinical-stage small molecule drug candidate that inhibits Casitas B-lineage lymphoma proto-oncogene-B (CBL-B).
Contact Information
- Headquarters
- 1700 Owens St Ste 205SAN FRANCISCO, CA, United States 94158-0006
- Phone
- 415-660-5320
- Fax
- 415-525-4200
Executives
- Independent Chairman of the Board
- Julia Gregory
- President, Chief Executive Officer, Director
- Arthur Sands
- Chief Financial Officer
- Hans van Houte
- Chief Technical Officer
- Pasit Phiasivongsa
- Chief Scientific Officer
- Gwenn Hansen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
|---|---|
Revenue (TTM) | $62.3M |
Shares Outstanding | 64.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.22 |
EPS | $-2.92 |
Book Value | $4.12 |
P/E Ratio | -7.6x |
Price/Sales (TTM) | 22.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -287.47% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
